Boston Business Journal [1] |
Zafgen's IND for diabetes treatment placed on hold by FDA [2]
MarketWatch Zafgen Inc. ZFGN, -40.55% said Monday the Food and Drug Administration ha placed a clinical hold on its investigational new drug application (IND) for the biopharmaceutical company's first U.S. clinical trial of its type 2 diabetes treatment, citing … Officials with FDA Halt US Trials for Diabetes Drug [3]Pharmacy Times Zafgen shares cut in half after FDA halts diabetes drug trial [1]Boston Business Journal Trending News Today: FDA Halts US Trials for Diabetes Drug [4]Specialty Pharmacy Times BioSpace (press release) (blog) [5] –Schaeffers Research (blog) [6] all 49 news articles » [7] |
More details can be found at www.diabeteshowto.com [8]